XSHE
300313
Market cap270mUSD
Jun 16, Last price
6.86CNY
1D
-3.28%
1Q
11.71%
Jan 2017
-67.37%
IPO
-16.41%
Name
Xinjiang Tianshan Animal Husbandry Bio-Engineering Co Ltd
Chart & Performance
Profile
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in cattle and sheep breeding activities in China. The company engages in the improvement of cattle and sheep varieties, relying on biological genetic technology to provide embryo and other genetic materials and related services for the livestock industry. It is also involved in breeding, fattening, slaughtering, processing, and selling beef cattle; and slaughtering beef and mutton products. The company was founded in 2003 and is based in Changji, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 137,500 80.09% | 76,350 -29.29% | |||||||
Cost of revenue | 133,899 | 73,136 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 3,601 | 3,214 | |||||||
NOPBT Margin | 2.62% | 4.21% | |||||||
Operating Taxes | 2,777 | 1,575 | |||||||
Tax Rate | 77.13% | 48.99% | |||||||
NOPAT | 824 | 1,640 | |||||||
Net income | (22,002) | ||||||||
Dividends | (5,495) | ||||||||
Dividend yield | 0.18% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 174,831 | 94,708 | |||||||
Long-term debt | 3,981 | 2,432 | |||||||
Deferred revenue | 8,718 | 9,302 | |||||||
Other long-term liabilities | 1,950 | 1,168 | |||||||
Net debt | 115,454 | (7,423) | |||||||
Cash flow | |||||||||
Cash from operating activities | (13,748) | ||||||||
CAPEX | (1,645) | (1,651) | |||||||
Cash from investing activities | 712 | (659) | |||||||
Cash from financing activities | (17,517) | ||||||||
FCF | (62,542) | (378,756) | |||||||
Balance | |||||||||
Cash | 16,735 | 47,288 | |||||||
Long term investments | 46,623 | 57,275 | |||||||
Excess cash | 56,483 | 100,746 | |||||||
Stockholders' equity | 322,802 | 322,884 | |||||||
Invested Capital | 203,001 | 99,119 | |||||||
ROIC | 0.55% | 8.80% | |||||||
ROCE | 1.38% | 1.60% | |||||||
EV | |||||||||
Common stock shares outstanding | 312,977 | 312,977 | |||||||
Price | 9.84 59.74% | 6.16 -19.90% | |||||||
Market cap | 3,079,698 59.74% | 1,927,941 -19.90% | |||||||
EV | 3,204,976 | 2,034,908 | |||||||
EBITDA | 18,473 | 17,077 | |||||||
EV/EBITDA | 173.50 | 119.16 | |||||||
Interest | 11,004 | 14,101 | |||||||
Interest/NOPBT | 305.58% | 438.73% |